Participants’ characteristics. حسب Jesús Poch-Páez (21807825)

الموضوعات:

Sources of infection. حسب Jesús Poch-Páez (21807825)

الموضوعات:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"

Absolute and relative ischaemic heart disease DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

الموضوعات:

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

الموضوعات:

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

الموضوعات:

The change of disease burden of CRD by sex in Fujian, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

The change of disease burden of CRD by age groups in Fujian, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

The change of disease burden of CRD by categories in Fujian, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

The proportion of attributable risk factors of DALYs of CRD in Fujian, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

The change of attribute risk factors of DALYs in CRD in Fujian, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

The change of disease burden of CRD in different region, 1990-2021. حسب Yanrong Yin (14292683)

الموضوعات:

PRISMA flow chart of the screening process. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Forest plot of liver function tests. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of BUN based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of ICU Stay based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Subgroup analysis of eGFR based on pump type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

GRADE evidence profile. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Characteristics of included studies. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات: